Techniques of ERCP with a conventional endoscope in pancreatoduodenectomy anatomy

Matsushita, Masayuki; Koyabu, Masanori; Nishio, Akiyoshi; Seki, Toshihito; Okazaki, Kazuichi

doi:10.1016/j.gie.2017.05.007

Cited by 7 publications

(4 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ERCP, a comparatively more complicated integral therapeutic modality among endoscopic techniques, is clinically the most common and specialized procedure used for the diagnosis and treatment of pancreatic and biliary system disorders[3-8]. Although it is superior to the traditional operation due to limited trauma, simplicity of the operation, and short recovery time in the treatment and diagnosis of duodenal and pancreatobiliary disorders[5,6], diagnostic and therapeutic ERCP can cause various complications such as pancreatitis, cholangitis, perforation, hemorrhage (especially postsphincterotomy), cholecystitis, cardiopulmonary depression, asymptomatic hyperamylasemia, aspiration, hypoxia, bleeding, sepsis, adverse medication reactions, and death[9-16].…”

Section: Introductionmentioning

confidence: 99%

Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment

Pekgöz

2019

WJG

View full text Add to dashboard Cite

BACKGROUND Post endoscopic retrograde cholangiopancreatography (ERCP) is comparatively complex application. Researchers has been investigated prevention of post-ERCP pancreatitis (PEP), since it has been considered to be the most common complication of ERCP. Although ERCP can lead various complications, it can also be avoided. AIMS To study the published evidence and systematically review the literature on the prevention and treatment for PEP. METHODS A systematic literature review on the prevention of PEP was conducted using the electronic databases of ISI Web of Science, PubMed and Cochrane Library for relevant articles. The electronic search for the review was performed by using the search terms “Post endoscopic retrograde cholangiopancreatography pancreatitis” AND “prevention” through different criteria. The search was restricted to randomized controlled trials (RCTs) performed between January 2009 and February 2019. Duplicate studies were detected by using EndNote and deleted by the author. PRISMA checklist and flow diagram were adopted for evaluation and reporting. The reference lists of the selected papers were also scanned to find other relevant studies. RESULTS 726 studies meeting the search criteria and 4 relevant articles found in the edited books about ERCP were identified. Duplicates and irrelevant studies were excluded by screening titles and abstracts and assessing full texts. 54 studies were evaluated for full text review. Prevention methods were categorized into three groups as (1) assessment of patient related factors; (2) pharmacoprevention; and (3) procedural techniques for prevention. Most of studies in the literature showed that young age, female gender, absence of chronic pancreatitis, suspected Sphincter of Oddi dysfunction, recurrent pancreatitis and history of previous PEP played a crucial role in posing high risks for PEP. 37 studies designed to assess the impact of 24 different pharmacologic agents to reduce the development of PEP delivered through various administration methods were reviewed. Nonsteroidal anti-inflammatory drugs are widely used to reduce risks for PEP. Rectal administration of indomethacin immediately prior to or after ERCP in all patients is recommended by European Society for Gastrointestinal Endoscopy guidelines to prevent the development of PEP. The majority of the studies reviewed revealed that rectally administered indomethacin had efficacy to prevent PEP. Results of the other studies on the other pharmacological interventions had both controversial and promising results. Thirteen studies conducted to evaluate the efficacy of 4 distinct procedural techniques to prevent the development of PEP were reviewed. Pancreatic Stent Placement has been frequently used in this sense and has potent and promising benefits in the prevention of PEP. Studies on the other procedural techniques have had inconsistent results. CONCLUSION Prevention of PE...

show abstract

Section: Introductionmentioning

confidence: 99%

Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment

Pekgöz

2019

WJG

View full text Add to dashboard Cite

show abstract

“…Problems in the liver, gallbladder, bile and pancreatic ducts, duodenal diverticula, and fistulas including esophagus, stomach, pancreas, and biliary duct diseases can be diagnosed. During the procedure, some problems can be treated (1,2). In our study, the most common ERCP indications were choledocholithiasis and fibrotic strictures.…”

Section: Discussionmentioning

confidence: 67%

“…Bu konuda çok merkezli prospektif çalışmalara ihtiyaç vardır. Adana Seyhan Devlet Hastanesi, 1 Gastroenteroloji Bölümü, Adana Koç Üniversitesi Tıp Fakültesi Hastanesi, 2 Gastroenteroloji Bölümü, İstanbul…”

Section: Abstract: Ercp Pep Pancreatitis Nlr Neutrophil Lymphocyteunclassified

Post-Endoskopik Retrograd Kolanjiyopankreatografi Pankreatitinde Olası Risk Faktörlerinin ve Prognostik Belirteçlerin Araştırılması

Abaylı¹,

Gençdal

2020

Endoskopi Gastrointestinal

View full text Add to dashboard Cite

but in recent years, diagnostic ERCP has been less used because of imaging techniques such as magnetic resonance cholangiography (MRCP) and endoscopic ultrasonography (EUS) (1,2). The complication rates and frequency after ERCP, the definition of complications, data collection methods, and patient selection show variations depending on the techniques and studies design. The most common complications related to ERCP are bleeding, perforation, infection, and pancreatitis.

show abstract

“…1 It allows access to biliary and pancreatic ducts for diagnosis as well as management without risks of prolonged anesthesia, surgical trauma, surgical complications and extended hospital stay for post-operative recovery with technically difficult pancreatico-biliary surgeries. 2 In last few decades, with availability of sophisticated new accessories of ERCP, range of therapeutic interventions possible in ERCP has remarkably extended. However, this has resulted in increasing incidence of complications like post ERCP pancreatitis, cholangitis, iatrogenic bleeding, sepsis, perforation etc.…”

Section: Introductionmentioning

confidence: 99%

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis

2020

View full text Add to dashboard Cite

Objective: To determine efficacy of diclofenac suppository in reducing post-ERCP pancreatitis (PEP) and identify risk factors for PEP. Methods: This is a placebo-based prospective study at Department of Medicine & Gastroenterology, Services Institute of Medical Sciences / Services Hospital, Lahore performed from January 2018 to June 2019. Patients were randomized to receive diclofenac suppository or glycerine suppository before ERCP. Both groups were compared for PEP using chi square x2 test while risk factors for PEP were determined using binary logistic regression. Results: Total of 165 patients with mean age 49.1(±15.2) and male to female ratio 1/1.6 (63/102) were included. Among 82 (49.7%) patients in diclofenac group, 8 (9.7%) developed pancreatitis while 19(22.9%) of 83(50.3%) in placebo group had PEP (p value 0.02). After multivariate analysis, age>45 years (p value 0.014, OR 3.2), Bilirubin >3 mg/dl (p value 0.004 OR 3.58), time to cannulation> 5 minutes (p value<0.000 OR 9.2), use of precut (p value< 0.000 OR 4.9), pancreatic duct cannulation (p value 0.000 OR 5.46) and total procedure time >30 minutes (p value 0.01 OR 3.92) were risk factors for PEP. Conclusion: Pre-procedure Diclofenac suppository reduces post-ERCP pancreatitis. Age > 45 years, serum bilirubin > 3 mg/dl, cannulation time > 5 minutes, use of precut, pancreatic duct cannulation and procedure time > 30 minutes are risk factors for post-ERCP pancreatitis. doi: https://doi.org/10.12669/pjms.36.3.1804 How to cite this:Nawaz MH, Sarwar S, Nadeem MA. Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis. Pak J Med Sci. 2020;36(3):---------. doi: https://doi.org/10.12669/pjms.36.3.1804 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Techniques of ERCP with a conventional endoscope in pancreatoduodenectomy anatomy

Cited by 7 publications

References 8 publications

Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment

Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment

Post-Endoskopik Retrograd Kolanjiyopankreatografi Pankreatitinde Olası Risk Faktörlerinin ve Prognostik Belirteçlerin Araştırılması

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis

Contact Info

Product

Resources

About